Calico LLC
E35320
Calico LLC is a research and development company focused on understanding aging and developing technologies to extend human healthspan, backed by Alphabet Inc.
Aliases (2)
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
Alphabet Inc. subsidiary
→
biotechnology company → research and development company → |
| aimsTo |
develop interventions to extend healthy human lifespan
→
understand the biology that controls lifespan → |
| alsoKnownAs |
Calico
→
California Life Company → |
| backedBy |
Alphabet Inc.
→
|
| CEO |
Arthur D. Levinson
→
|
| chairman |
Arthur D. Levinson
→
|
| collaboratesWith |
AbbVie
→
|
| country |
United States
→
|
| enteredStrategicR&DAllianceWith |
AbbVie
→
|
| focusesOn |
age-related diseases
→
aging research → cancer → extending human healthspan → longevity research → metabolic diseases → neurodegenerative diseases → |
| foundedBy |
Bill Maris
→
Larry Page → |
| foundedInYear |
2013
→
|
| hasLongTermR&DInvestmentAgreementWith |
AbbVie
→
|
| hasResearchCollaboration |
AbbVie
→
|
| hasType |
privately held company
→
|
| headquartersLocation |
South San Francisco, California
NERFINISHED
→
|
| industry |
biotechnology
→
life sciences → pharmaceuticals → |
| keyPerson |
Arthur D. Levinson
→
Cynthia Kenyon → David Botstein → Hal V. Barron → |
| name |
Calico LLC
→
|
| parentCompany |
Alphabet Inc.
→
|
| partOf |
Alphabet Inc.
→
|
| regionServed |
global
→
|
| researchArea |
cellular senescence
→
computational biology → drug discovery → genomics → molecular biology of aging → stem cell biology → |
| state |
California
→
|
| subsidiaryOf |
Alphabet Inc.
→
|
| usesApproach |
basic biological research
→
translational research → |
Referenced by (5)
| Subject (surface form when different) | Predicate |
|---|---|
|
Arthur D. Levinson
("Calico Life Sciences")
→
Daphne Koller ("Calico Labs") → |
employer |
|
Calico LLC
→
|
name |
|
Alphabet Inc.
→
|
parentCompanyOf |
|
Alphabet Inc.
→
|
subsidiary |